Liga Chem Biosciences (KRX: 141080)
Who is buying Liga Chem Biosciences?
Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net sold ₩0.3bn ($0M) of Liga Chem Biosciences, the 379th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net sold ₩34.8bn ($26M) and retail investors net bought ₩31.0bn ($23M) over the same window. Foreigners were net buyers on 13 of the 20 sessions.
Foreign investors hold 12.97% of Liga Chem Biosciences' listed shares (KRX ownership data as of Oct 16, 2026), down from 13.09% twenty sessions earlier and 11.07% a year ago.
The stock closed at ₩68,300 on Oct 16, 2026: -19.36% over 20 sessions, -60.68% year-to-date, -48.49% over one year. The 52-week range is ₩61,600 – ₩225,000.
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-10-16 | ₩68,300 | +₩4.3bn | +₩0.7bn | ₩-5.7bn |
| 2026-10-15 | ₩62,800 | +₩2.7bn | +₩1.2bn | ₩-5.1bn |
| 2026-10-14 | ₩66,100 | +₩1.9bn | ₩-1.9bn | ₩-1.5bn |
| 2026-10-13 | ₩65,500 | +₩1.9bn | +₩0.1bn | ₩-1.9bn |
| 2026-10-12 | ₩69,100 | +₩4.2bn | ₩-3.0bn | ₩-1.3bn |
| 2026-10-08 | ₩73,300 | ₩-2.9bn | ₩-10.8bn | +₩13.5bn |
| 2026-10-07 | ₩80,500 | ₩-9.6bn | ₩-3.2bn | +₩12.6bn |
| 2026-10-06 | ₩83,900 | ₩-0.6bn | +₩0.1bn | +₩0.5bn |
| 2026-10-02 | ₩82,300 | ₩-11.5bn | +₩0.6bn | +₩10.7bn |
| 2026-10-01 | ₩86,200 | +₩1.8bn | +₩6.4bn | ₩-8.2bn |
| 2026-09-30 | ₩79,800 | +₩0.6bn | +₩0.1bn | ₩-0.7bn |
| 2026-09-29 | ₩79,500 | +₩0.7bn | ₩-2.8bn | +₩2.5bn |
| 2026-09-28 | ₩79,800 | ₩-4.1bn | ₩-4.0bn | +₩8.2bn |
| 2026-09-23 | ₩80,800 | +₩0.8bn | ₩-1.6bn | +₩0.8bn |
| 2026-09-22 | ₩80,200 | ₩-0.7bn | ₩-0.2bn | +₩0.9bn |
| 2026-09-21 | ₩81,900 | +₩3.2bn | ₩-1.7bn | ₩-1.5bn |
| 2026-09-18 | ₩82,200 | ₩-2.6bn | ₩-0.6bn | +₩3.1bn |
| 2026-09-17 | ₩83,200 | +₩2.5bn | ₩-3.7bn | +₩1.1bn |
| 2026-09-16 | ₩82,600 | +₩6.9bn | ₩-9.1bn | +₩2.2bn |
| 2026-09-15 | ₩83,700 | +₩0.4bn | ₩-1.3bn | +₩0.9bn |
| 2026-09-14 | ₩84,700 | +₩3.4bn | ₩-0.7bn | ₩-2.7bn |
| 2026-09-11 | ₩85,200 | +₩4.8bn | ₩-6.7bn | +₩2.3bn |
| 2026-09-10 | ₩87,600 | +₩9.8bn | ₩-15.1bn | +₩5.2bn |
| 2026-09-09 | ₩90,300 | +₩3.1bn | ₩-4.9bn | +₩1.8bn |
| 2026-09-08 | ₩89,300 | +₩6.0bn | ₩-5.7bn | ₩-0.1bn |
| 2026-09-07 | ₩92,300 | ₩-0.4bn | ₩-0.9bn | +₩1.2bn |
| 2026-09-04 | ₩92,000 | +₩3.8bn | +₩1.9bn | ₩-5.3bn |
| 2026-09-03 | ₩88,300 | +₩1.0bn | ₩-5.0bn | +₩4.5bn |
| 2026-09-02 | ₩90,800 | +₩4.6bn | ₩-3.9bn | ₩-0.7bn |
| 2026-09-01 | ₩94,900 | +₩4.7bn | ₩-6.2bn | +₩1.5bn |
| 2026-08-31 | ₩96,500 | +₩2.7bn | ₩-9.3bn | +₩6.8bn |
| 2026-08-28 | ₩101,000 | ₩-2.4bn | +₩0.4bn | +₩2.0bn |
| 2026-08-27 | ₩99,600 | +₩4.0bn | ₩-1.1bn | ₩-3.1bn |
| 2026-08-26 | ₩98,300 | ₩-1.8bn | ₩-6.6bn | +₩8.2bn |
| 2026-08-25 | ₩99,700 | +₩1.6bn | ₩-4.9bn | +₩3.6bn |
| 2026-08-24 | ₩102,900 | +₩6.5bn | +₩1.9bn | ₩-8.2bn |
| 2026-08-21 | ₩100,000 | +₩3.3bn | ₩-9.4bn | +₩5.9bn |
| 2026-08-20 | ₩108,300 | +₩1.1bn | +₩1.9bn | ₩-2.9bn |
| 2026-08-19 | ₩104,400 | +₩3.7bn | ₩-1.2bn | ₩-2.5bn |
| 2026-08-18 | ₩105,100 | +₩11.3bn | ₩-16.6bn | +₩6.7bn |
| 2026-08-14 | ₩113,900 | +₩3.4bn | ₩-6.2bn | +₩2.6bn |
| 2026-08-13 | ₩114,400 | +₩16.7bn | ₩-19.0bn | +₩3.4bn |
| 2026-08-12 | ₩115,100 | +₩14.6bn | ₩-14.3bn | ₩-2.4bn |
| 2026-08-11 | ₩116,900 | +₩1.3bn | ₩-7.1bn | +₩1.2bn |
| 2026-08-10 | ₩119,900 | ₩-20.5bn | +₩16.6bn | +₩3.5bn |
| 2026-08-07 | ₩113,200 | ₩-5.7bn | +₩3.5bn | +₩1.7bn |
| 2026-08-06 | ₩110,900 | ₩-13.3bn | +₩7.1bn | +₩5.5bn |
| 2026-08-05 | ₩109,500 | ₩-9.4bn | +₩2.3bn | +₩4.3bn |
| 2026-08-04 | ₩109,900 | ₩-16.0bn | +₩23.7bn | ₩-7.6bn |
| 2026-08-03 | ₩95,400 | ₩-4.6bn | +₩10.3bn | ₩-6.1bn |
| 2026-07-31 | ₩87,500 | +₩0.8bn | +₩5.6bn | ₩-6.0bn |
| 2026-07-30 | ₩77,900 | +₩8.9bn | ₩-7.5bn | ₩-1.3bn |
| 2026-07-29 | ₩82,900 | +₩26.5bn | ₩-3.7bn | ₩-14.1bn |
| 2026-07-28 | ₩90,600 | +₩7.3bn | ₩-0.1bn | ₩-6.5bn |
| 2026-07-27 | ₩97,600 | ₩-3.0bn | +₩4.0bn | ₩-0.8bn |
| 2026-07-24 | ₩96,100 | +₩2.4bn | ₩-3.0bn | +₩1.5bn |
| 2026-07-23 | ₩101,700 | ₩-0.1bn | +₩3.1bn | ₩-2.8bn |
| 2026-07-22 | ₩93,900 | +₩7.4bn | ₩-4.2bn | ₩-2.6bn |
| 2026-07-21 | ₩93,600 | +₩26.3bn | ₩-23.8bn | +₩0.6bn |
| 2026-07-20 | ₩97,100 | +₩5.6bn | ₩-5.2bn | ₩-0.3bn |
| 2026-07-16 | ₩103,700 | +₩9.3bn | ₩-7.4bn | ₩-0.5bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩4.3bn | +$3M | +₩0.7bn | ₩-5.7bn |
| 5 days | +₩14.9bn | +$11M | ₩-2.9bn | ₩-15.5bn |
| 20 days | ₩-0.3bn | $-0M | ₩-34.8bn | +₩31.0bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Frequently asked questions
Are foreign investors buying Liga Chem Biosciences stock?
Over the last 5 sessions foreign investors net bought ₩14.9bn ($11M) of Liga Chem Biosciences; over 60 sessions they net bought ₩119.1bn ($89M); since Jan 1, 2026 they net bought ₩55.5bn ($41M). Over 20 sessions the stock is the 379th largest foreign net sale among 1828 KOSDAQ stocks.
How much of Liga Chem Biosciences do foreign investors own?
Foreign investors own 12.97% of Liga Chem Biosciences' shares as of Oct 16, 2026, versus 11.07% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.
Who is on the other side — institutions or retail investors?
Over 20 sessions institutions net sold ₩34.8bn ($26M) and retail investors net bought ₩31.0bn ($23M) of Liga Chem Biosciences. Retail investors have been absorbing what foreigners and institutions are selling.
Is Liga Chem Biosciences listed on KOSPI or KOSDAQ?
Liga Chem Biosciences (리가켐바이오) trades on KOSDAQ under KRX code 141080 in the Biotech & Pharma group, with a market capitalization of ₩3T ($1.9B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | – | – | -₩81bn (-$60M) | -₩74bn (-$55M) |
| 2024 | – | – | -₩21bn (-$16M) | ₩8bn ($6M) |
| 2025 | ₩142bn ($105M) | – | -₩106bn (-$79M) | -₩92bn (-$68M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.